Table 4.
Identified groups of DS-TB patients and radiological characteristics.
| # patient | Radiological characteristics | Comorbidities | Average age (years) | ||
|---|---|---|---|---|---|
|
GROUP I.
Pro-inflammatory cytokines and platelet factors elevation |
1 | Two caverns in RLL | 100% Presence of cavitations | 50% Type 2 Diabetes mellitus | 41.5 |
| 2 | Caverns in LUL | ||||
|
GROUP II.
Platelet factors elevation but not pro-inflammatory cytokines |
3 | Both upper lobes with cavitated lesions | 66.6% presence of cavitations. 33.3% Lung affection without cavitations. |
33.3% Type 2 Diabetes mellitus | 39 |
| 4 | Left apical caverns, cavern at the level of lingula, superior segment of LLL with two caverns | ||||
| 5 | Right basal consolidation, reticulonodular pattern | ||||
|
GROUP III.
Main elevation of pro-inflammatory cytokines |
6 | Adenopathies, multiple cavitations. Loss of left pulmonary parenchyma. | 66.6% presence of adenopathies. 100% destruction of lung parenchyma. 100% presence of cavitations. | 100% Type 2 Diabetes mellitus. 33.3% Previous pulmonary disease. 33.3% Dyslipidemia. 33.3% Smoking. |
44 |
| 7 | Adenopathies, multiple cavitations, destruction of right lung parenchyma | ||||
| 8 | Multiple caverns. Lung parenchymal destruction in the LUL. | ||||
| GROUP IV. Low levels of platelet factors and pro-inflammatory cytokines | 9 | Pulmonary nodule | 100% Lung affection without cavitations | None | 35.5 |
| 10 | Bilateral reticular pattern, pleural thickening | ||||
RLL, Right Lower Lobe; LUL, Left Upper Lobe; LLL, Left Lower Lobe.